Correlation Between VentriPoint Diagnostics and Hemostemix

Can any of the company-specific risk be diversified away by investing in both VentriPoint Diagnostics and Hemostemix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentriPoint Diagnostics and Hemostemix into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between VentriPoint Diagnostics and Hemostemix, you can compare the effects of market volatilities on VentriPoint Diagnostics and Hemostemix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentriPoint Diagnostics with a short position of Hemostemix. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentriPoint Diagnostics and Hemostemix.

Diversification Opportunities for VentriPoint Diagnostics and Hemostemix

0.3

Correlation Coefficient

VentriPoint Diagnostics  Hemostemix

Weak diversification

The 3 months correlation between VentriPoint and Hemostemix is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding VentriPoint Diagnostics and Hemostemix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hemostemix and VentriPoint Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentriPoint Diagnostics are associated (or correlated) with Hemostemix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hemostemix has no effect on the direction of VentriPoint Diagnostics i.e., VentriPoint Diagnostics and Hemostemix go up and down completely randomly.

Pair Corralation between VentriPoint Diagnostics and Hemostemix

Assuming the 90 days horizon VentriPoint Diagnostics is expected to under-perform the Hemostemix. But the stock apears to be less risky and, when comparing its historical volatility, VentriPoint Diagnostics is 1.65 times less risky than Hemostemix. The stock trades about -0.13 of its potential returns per unit of risk. The Hemostemix is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  8.50  in Hemostemix on September 19, 2024 and sell it today you would lose (1.00) from holding Hemostemix or give up 11.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

VentriPoint Diagnostics  vs.  Hemostemix

VentriPoint Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Hemostemix

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Hemostemix are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Hemostemix showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with VentriPoint Diagnostics and Hemostemix

The main advantage of trading using opposite VentriPoint Diagnostics and Hemostemix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentriPoint Diagnostics position performs unexpectedly, Hemostemix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemostemix will offset losses from the drop in Hemostemix's long position.

The idea behind VentriPoint Diagnostics and Hemostemix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.